EMD Millipore: Depend(Ab)le – Stem Cell Antibodies
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
List view / Grid view
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
10 May 2016 | By Merck KGaA
Complete product portfolio for the study of cell structure, intracellular signaling, extracellular environment, and cellular migration and invasion...
28 April 2016 | By Merck KGaA
Each of EMD Millipore’s ChIPAb+™ and RIPAb+™ antibodies are validated and tested for ChIP and RNA immunoprecipitation (RIP)...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
1 March 2016 | By Merck KGaA
With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analysing all the hallmarks of cancer...
23 February 2016 | By DiscoverX Corporation
PathHunter cell-based pharmacotrafficking assays provide a simple and quantitative tool for broad pharmacological characterisation and interrogation of compound function in disease processes associated with protein trafficking and internalization due to protein misfolding...
23 February 2016 | By DiscoverX Corporation
The most comprehensive kinase inhibitor screening panel with over 480 kinase assays to screen against on a single technology platform...
22 February 2016 | By DiscoverX Corporation
The KILR Cytotoxicity Assay is a simple, non-radioactive and dye-free method to specifically measure target cancer cell cytotoxicity...
22 February 2016 | By DiscoverX Corporation
GPCRscan is a functional cell-based GPCR assay panel for profiling drug compounds during drug discovery...
19 February 2016 | By DiscoverX Corporation
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA...
19 February 2016 | By DiscoverX Corporation
PathHunter® Checkpoint Assays enable screening and potency assays for the development of immunotherapy drugs...
A concise overview of some of the key features for the use of antibodies and immunochemical techniques in biological research...
12 February 2016 | By DiscoverX Corporation
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients...
12 February 2016 | By DiscoverX Corporation
PathHunter® bioassays are cell-based assays that are highly validated, simple, and target specific to support biologics drug development...